This is a 360 degree image showing the main hybrid cath lab at Henry Ford Hospital in Detroit, which is used for most of the structural heart procedures performed at that center. It uses a Philips Azurion angiography system, which is a low dose imaging system that significantly reduces X-ray exposure compared to previous generation systems.

Medtronic has received U.S. Food and Drug Administration (FDA) approval for the Attain Stability Quad MRI SureScan left heart lead. Paired with Medtronic quadripolar cardiac resynchronization therapy-defibrillators (CRT-D) and -pacemakers (CRT-P), the Attain Stability Quad lead is the only active-fixation left heart lead, according to the company, and is designed for precise lead placement and stability. The lead will be commercially available in the U.S. in summer 2019.

According to the National Association of County and City Health Officials, only 33 percent of the organizations plan against cybersecurity threats and initiate patient identity protection protocols.

As the National Association of County and City Health Officials state, healthcare breaches remained to be costly and disastrous for the organizations in 2018. Each patient record exposure can cost up to $400, and hackers always try to access the medical information of hundreds of thousands of patients at once.

Abbott announced the launch of a new, smarter heart monitor for better arrhythmia detection — positive news for people at risk for irregular heartbeats. Now with CE Mark in Europe and U.S. Food and Drug Administration (FDA) clearance, the next-generation Confirm Rx insertable cardiac monitor (ICM), a paperclip-sized implantable device, combines smartphone connectivity and continuous, remote monitoring to track unpredictable heart rhythm problems for fast and accurate diagnosis.

May 6, 2019 — The U.S Food and Drug Administration (FDA) has cleared the Boston Scientific Vici Venous Stent System for the treatment of iliofemoral venous obstructive disease. These blockages occur when the flow of blood through the veins located deep in the pelvic region becomes blocked by a blood clot or compressed by anatomical anomalies.

May 6, 2019 — The U.S. Food and Drug Administration (FDA) approved tafamidis meglumine (Vyndaqel) and tafamidis (Vyndamax) capsules for the treatment of the cardiomyopathy caused by transthyretin mediated amyloidosis (ATTR-CM) in adults. These are the first FDA-approved treatments for ATTR-CM. 

Innovation in Cardiovascular Interventions (ICI)

Bioengineers have cleared a major hurdle on the path to 3-D printing replacement organs with a breakthrough technique for bioprinting tissues. The new innovation allows scientists to create exquisitely entangled vascular networks that mimic the body's natural passageways for blood, air, lymph and other vital fluids.

A discussion with Gianluca Pontone, M.D., Ph.D., FSCCT, director of cardiovascular MRI, Centro Cardiologico Manzino, Milan, Italy, at the Society of Cardiovascular Computed Tomography (SCCT) 2018 meeting. He said CT can be comparable to the gold-standards of nuclear and MRI perfusion depending on the scanner used to acquire the images. 

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now